CHICAGO, Ill., Sept. 10, 2019 (SEND2PRESS NEWSWIRE) — Aclaro Inc., the game-changing Artificial Intelligence software company that provides disruptive technologies to the automotive, financial, and government sectors, announces a new Board Member and the release of Aclaro EcoSystem 3.0 (ES 3.0). With these announcements, Aclaro continues rapid advancement toward its overarching mission of helping lenders, dealers and consumers develop and nurture longer mutually beneficial relationships.
Artificial Intelligence News
News items related to Artificial Intelligence as issued by the Send2Press Newswire service on behalf of the noted news source.
viv, Co. Releases an Application Predicting Baby’s Schedule of Development Milestones by Artificial Intelligence (AI) and Supporting Baby-Care
| From: viv Co
LOS ANGELES, Calif., Aug. 26, 2019 (SEND2PRESS NEWSWIRE) — viv, Co. (CEO: Kyo Ueda) announced today that they are moving forward with the “BabyLook” project of “visualizing baby’s mind” by using baby’s facial expression and body information is going to release BabyLook:ver2.0; the application of predicting baby’s development.
Save A Life and Protect Your Family for Life – Zanthion Launches AI Digital Healthcare SMART Lifetime Bundle
| From: Zanthion
SAN FRANCISCO, Calif., Aug. 23, 2019 (SEND2PRESS NEWSWIRE) — Zanthion launches SMART Lifetime, a complete personal and home security system for life, with no subscription fees and proactive health monitoring with crowdsourced awareness. Zanthion is an AI digital healthcare company with a class-leading Senior Care IoT Platform.
| From: Zanthion
SAN FRANCISCO, Calif., June 14, 2019 (SEND2PRESS NEWSWIRE) — John Hagelgans has joined Zanthion(TM) as their new CTO. Zanthion spent over a year looking for a new chief technology officer based in the United States with the integrity and intelligence to help them achieve dominance in the elderly care market.
| From: INNOGATE
NEW YORK, N.Y., March 22, 2019 (SEND2PRESS NEWSWIRE) — INNOGATE, a Turkish based international technology accelerator, announced today it will be launching its 360-degree International Acceleration Program in March, touring select Turkish based technology firms on a strategic U.S. Roadshow until March 31, 2019.
| From: Aclaro
MIAMI, Fla., Aug. 2, 2018 (SEND2PRESS NEWSWIRE) — Aclaro, the leading provider in blockchain-based open platform solutions, recently released its latest A.I. solution. The new tool, Aclaro TrueView is designed to provide automotive and other lenders with a competitive advantage through robust features that save them time, money, and facilitate better lending decisions.
| From: Aclaro
MIAMI, Fla., July 11, 2018 (SEND2PRESS NEWSWIRE) — Aclaro, the leading provider of blockchain based open data platforms and solutions, has announced that it has launched a new Fintech Artificial Intelligence (AI) solution focused on the lending industry. The new solution is Aclaro TrueView. Aclaro aims to equip lenders with the innovative tools needed for competitive advantage with its tech savvy, blockchain based predictive analytics platform that can be utilized without incurring heavy costs.
| From: CounterFlow AI
CHARLOTTESVILLE, Va., Feb. 27, 2018 (SEND2PRESS NEWSWIRE) — Cybersecurity startup CounterFlow AI announced last week that it has raised $2.7 million in seed funding from Osage University Partners, the Charlottesville Angel Network, and a number of individual investors who also supported the founders’ previous venture, nPulse Technologies (acquired by FireEye in 2014).
Pharma companies gain competitive advantage from 1 day Masterclass on Artificial Intelligence in Pharma sales and marketing
| From: Eularis
NEW YORK, N.Y., Aug. 2, 2016 (SEND2PRESS NEWSWIRE) — Eularis announces the release of their one-day Masterclass “Using Artificial Intelligence to Transform Sales and Revenue: What Pharma Need to Know.” Many Pharma sales and marketing teams do not understand the relevance, nor the critical importance, of AI to achieve stronger results in their roles, and believe it is not relevant to them or their job. This is an incorrect assumption.